Pfizer raises Covid-19 vaccine sales forecast to $36bn for 2021

business
Pfizer Raises Covid-19 Vaccine Sales Forecast To $36Bn For 2021 Pfizer Raises Covid-19 Vaccine Sales Forecast To $36Bn For 2021
Pfizer expects to deliver 2.3 billion doses of the vaccine, out of the roughly 3 billion it expects to make this year
Share this article

Thomson Reuters

Pfizer Inc on Tuesday raised the full-year sales forecast for its Covid-19 vaccine by 7.5% to $36 billion (€30.95 billion), as it signs deals with countries for booster doses and receives clearances for using its shots in children.

The company had in July forecast sales of $33.5 billion from the vaccine it sells with BioNTech.

Driven by an unprecedented vaccination drive against the Covid-19 pandemic globally, Pfizer's shot has quickly become one of the best-selling products in the company's roughly 172-year history.

The company, which was well known for drugs such as Xanax and Viagra, equally splits expenses and profit with its German partner.

Pfizer expects to deliver 2.3 billion doses of the vaccine, out of the roughly 3 billion it expects to make this year. - Reuters

Advertisement

Read More

Want us to email you top stories each lunch time?

Download our Apps
© BreakingNews.ie 2022, developed by Square1 and powered by PublisherPlus.com